RT @TheJHLT: This issue https://t.co/JVfhbLCUHd CLEAR-LVAD study shows among 4195 de-novo LVAD implants - HM3 risk adjusted mortality at 1-…
RT @TheJHLT: This issue https://t.co/JVfhbLCUHd CLEAR-LVAD study shows among 4195 de-novo LVAD implants - HM3 risk adjusted mortality at 1-…
RT @YasMoayedi: While there is definitely a role for patient centered care and the type of VAD we choose, CLEAR LVAD is compelling in showi…
RT @YasMoayedi: While there is definitely a role for patient centered care and the type of VAD we choose, CLEAR LVAD is compelling in showi…
RT @TheJHLT: This issue https://t.co/JVfhbLCUHd CLEAR-LVAD study shows among 4195 de-novo LVAD implants - HM3 risk adjusted mortality at 1-…
RT @YasMoayedi: While there is definitely a role for patient centered care and the type of VAD we choose, CLEAR LVAD is compelling in showi…
RT @YasMoayedi: While there is definitely a role for patient centered care and the type of VAD we choose, CLEAR LVAD is compelling in showi…
RT @TheJHLT: This issue https://t.co/JVfhbLCUHd CLEAR-LVAD study shows among 4195 de-novo LVAD implants - HM3 risk adjusted mortality at 1-…
RT @PalakShahMD: This provides real-world data to inform our patient discussions around long-term safety / efficacy of the newest generatio…
This provides real-world data to inform our patient discussions around long-term safety / efficacy of the newest generation centrifugal flow pumps.
RT @TheJHLT: This issue https://t.co/JVfhbLCUHd CLEAR-LVAD study shows among 4195 de-novo LVAD implants - HM3 risk adjusted mortality at 1-…
RT @YasMoayedi: While there is definitely a role for patient centered care and the type of VAD we choose, CLEAR LVAD is compelling in showi…
While there is definitely a role for patient centered care and the type of VAD we choose, CLEAR LVAD is compelling in showing reduced hospitalization and improved survival @ShelleyZieroth @shelleyhallmd @docbhardwaj @BrettSperryMD @KevinShahMD @StavrosDrak
RT @TheJHLT: This issue https://t.co/JVfhbLCUHd CLEAR-LVAD study shows among 4195 de-novo LVAD implants - HM3 risk adjusted mortality at 1-…
RT @TheJHLT: This issue https://t.co/JVfhbLCUHd CLEAR-LVAD study shows among 4195 de-novo LVAD implants - HM3 risk adjusted mortality at 1-…
RT @TheJHLT: This issue https://t.co/JVfhbLCUHd CLEAR-LVAD study shows among 4195 de-novo LVAD implants - HM3 risk adjusted mortality at 1-…
RT @TheJHLT: This issue https://t.co/JVfhbLCUHd CLEAR-LVAD study shows among 4195 de-novo LVAD implants - HM3 risk adjusted mortality at 1-…
RT @TheJHLT: This issue https://t.co/JVfhbLCUHd CLEAR-LVAD study shows among 4195 de-novo LVAD implants - HM3 risk adjusted mortality at 1-…
This issue https://t.co/JVfhbLCUHd CLEAR-LVAD study shows among 4195 de-novo LVAD implants - HM3 risk adjusted mortality at 1-year was superior to HMII/other. HM3 had fewer hospitalizations & less expenditures @FPaganiMD @preventfailure @tonkhueMdPhd @
RT @preventfailure: Thank you to the Heart Failure team at New York Presbyterian/Columbia- esp Dr. Melana Yuzefpolskaya- for the invite to…
Thank you to the Heart Failure team at New York Presbyterian/Columbia- esp Dr. Melana Yuzefpolskaya- for the invite to moderate Journal Club on Clear-LVAD. Shout out to Dr. Oh for a wonderfully organized presentation!!!! #heartfailure https://t.co/DflrQWm
Clinical Outcomes and Healthcare Expenditures in the Real-World with Left Ventricular Assist Devices – The CLEAR-LVAD Study - The Journal of Heart and Lung Transplantation https://t.co/uwvauy6pXR
RT @ACTION4HF: Something to think about in adolescents. More to come https://t.co/ztkbAiibv3
RT @josephspinner: Really impressive! So glad this device has been approved in children! Now excited to see what we learn about this devic…
Something to think about in adolescents. More to come
RT @preventfailure: Is it clear? Clearer? More clear? https://t.co/ZmxnUR8kHr
RT @josephspinner: Really impressive! So glad this device has been approved in children! Now excited to see what we learn about this devic…
RT @preventfailure: Is it clear? Clearer? More clear? https://t.co/ZmxnUR8kHr
RT @josephspinner: Really impressive! So glad this device has been approved in children! Now excited to see what we learn about this devic…
RT @josephspinner: Really impressive! So glad this device has been approved in children! Now excited to see what we learn about this devic…
RT @preventfailure: Is it clear? Clearer? More clear? https://t.co/ZmxnUR8kHr
Really impressive! So glad this device has been approved in children! Now excited to see what we learn about this device from @ACTION4HF: HM3 outcomes and expenditures The CLEAR-LVAD Study @TheJHLT. @LortsAngie @PuriKriti https://t.co/35pSierU7U
Better technology, better outcomes...
Is it clear? Clearer? More clear? https://t.co/ZmxnUR8kHr